The Effects of Hemodialysis Session on Vascular Stiffness

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Central blood pressure and pulse wave velocity were measured using a Complior Analyse device before and immediately after the end of the dialysis session.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis

NCT02485782

End Stage Renal Failure on Dialysis Body Fluid Retention Impedance +1 more

COMPLETED

The Effect of Nocturnal Haemodialysis on Arterial Stiffness

NCT00641875

End Stage Renal Disease Arterial Stiffness

COMPLETED

Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration

NCT00976846

End Stage Kidney Disease

COMPLETED NA

Body Composition Monitor Among Daily Home Dialysis With Low Flow Dialysate

NCT03994133

Chronic Kidney Disease Requiring Chronic Dialysis Hemodialysis, Home Electric Impedance

UNKNOWN

Tolerance of "on Line" Hemodiafiltration in Chronic Renal Failure Patients

NCT01327391

Cardiovascular Disease

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arteriopathic Disease Arterial Calcification Complication of Hemodialysis Aortic Stiffness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hemodialysis patients

Stable end-stage renal disease patients on maintenance conventional hemodialysis received 4-5 hours of treatment thrice weekly. Pulse wave velocity and central aortic pressure was measured before and after the midweek dialysis session.Overhydration Urea distribution volume (V) Total body water, extracellular and intracellular water Lean Tissue Index (LTI) Fat Tissue Index (FTI) Body Cell Mass (BCM) was measured before the midweek dialysis session just after Complior device

Complior Analyse System

Intervention Type DEVICE

Pulse Wave Velocity PWV and central Pressure analysis

BCM- Body Composition Monitor

Intervention Type DEVICE

BCM - Body Composition Monitor gives information about:

Overhydration Urea distribution volume (V) Total body water, extracellular and intracellular water Lean Tissue Index (LTI) Fat Tissue Index (FTI) Body Cell Mass (BCM)

Healthy subjects

Medical staff: medical doctors, nurses

Complior Analyse System

Intervention Type DEVICE

Pulse Wave Velocity PWV and central Pressure analysis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Complior Analyse System

Pulse Wave Velocity PWV and central Pressure analysis

Intervention Type DEVICE

BCM- Body Composition Monitor

BCM - Body Composition Monitor gives information about:

Overhydration Urea distribution volume (V) Total body water, extracellular and intracellular water Lean Tissue Index (LTI) Fat Tissue Index (FTI) Body Cell Mass (BCM)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* give voluntary consent to participate in the study
* patients on maintenance hemodialysis at least 3 months
* stable dry weight
* single-pool Kt/V \>1.4
* no clinical cardiovascular disease during the 6 months preceding entry
* medical staff (medical doctors, nurses)